Amylin Pharmaceuticals Inc

Type: Company

Name: Amylin Pharmaceuticals Inc (Amylin Pharmaceuticals)

Nationality: United States

Fact Sheet: Fact Sheet for Amylin Pharmaceuticals

First Reported 14 hours ago - Updated 14 hours ago - 1 Documents (in Health)

Alkermes Inc

Alkermes Retains Neutral Rec - Analyst Blog

We maintain our Neutral rating on Alkermes, Inc. ( ALKS ) with a price target of $11.50. Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery technologies to develop drugs for the treatment of central nervous ... [Benzinga.com - 14 hours ago]

Entities: Alkermes Inc, Exenatide, Risperdal, Food and Drug Administration

First Reported 10 hours ago - Updated 10 hours ago - 1 Documents (in Market News)

Affymetrix Inc

Biotech ETFs Immune To Broad Selling

While the broad market sold off the past four weeks and fell below the 10-week moving average, biotech ETFs held their heads above that key line. In doing so, the biotech ETFs resisted the market's downward pull and outperformed all of the S&P 500's 10 ... [Yahoo! Canada - 10 hours ago]

Entities: InterMune Incorporated, Affymetrix Inc, Biotechnology

First Reported 02/05/2010 - Updated 02/05/2010 - 1 Documents

Amylin Pharmaceuticals Inc

Form 4 AMYLIN PHARMACEUTICALS For: Feb 02 Filed by: KOLTERMAN ORVILLE G

Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AMYLIN+PHARMACEUTICALS++++For%3A+Feb+02++Filed+by%3A+KOLTERMAN+ORVILLE+G/5311547.html for the full story. ... [Street Insider - 02/05/2010]

Entities: Amylin Pharmaceuticals Inc

First Reported 01/26/2010 - Updated 01/27/2010 - 12 Documents (in Health)

Novo Nordisk

Rival diabetes drug's OK gives hope for Lilly treatment

Shares of Indianapolis-based Eli Lilly and Co. and Amylin Pharmaceuticals, its San Diego-based partner on diabetes treatment Byetta, moved higher Tuesday after federal health officials' approval of Danish drug maker Novo Nordisk's once-daily injection ... [Indianapolis Star - 01/27/2010]

Entities: Diabetes, Byetta, Amylin Pharmaceuticals Inc, Novo Nordisk

First Reported 01/12/2010 - Updated 01/13/2010 - 21 Documents (in Health)

Food and Drug Administration

FDA warns drug firms over adverts

The US Food and Drug Administration (FDA) has written to four pharmaceutical companies warning them over inaccuracies in the marketing of their drugs. Eli Lilly, Bayer, Amylin Pharmaceuticals and Cephalon all received letters warning them over inaccurate ... [Pharmacy Europe - 01/13/2010]

Entities: Food and Drug Administration, Cephalon Inc, Lilly (Pennsylvania, United States)

First Reported 01/12/2010 - Updated 01/12/2010 - 10 Documents (in Medicine)

Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 11, 2010 /PRNewswire via COMTEX/ ---- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced the 2010 corporate priorities that will position the Company to address the dual epidemics of diabetes and obesity, achieve positive ... [FOXBusiness.com - 01/12/2010]

Entities: Amylin Pharmaceuticals Inc, Exenatide, Diabetes, Byetta

First Reported 01/27/2010 - Updated 01/27/2010 - 2 Documents

Amylin Pharmaceuticals Reports 2009 Financial Results

SAN DIEGO, Jan. 27, 2010 -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2009. The Company reported tot... ... [Earthtimes.org - 01/27/2010]

Entities: Amylin Pharmaceuticals Inc, San Diego (California, United States)

First Reported 01/28/2010 - Updated 01/28/2010 - 2 Documents (in Market News)

Amylin Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript

Amylin Pharmaceuticals, Inc. (AMLN) Q4 2009 Earnings Call January 27, 2010 05:00 pm ETComplete Story » ... [Transcripts from Seeking Alpha - 01/28/2010]

Entities: Amylin Pharmaceuticals Inc

First Reported 01/13/2010 - Updated 01/14/2010 - 3 Documents (in Medicine)

FDA Warnings Issued Over Drug Company Marketing

The Food Drug Administration has issued warning letters to various drug companies over their promotional materials making inaccurate or incomplete claims. The Los Angeles Times reports that the FDA warnings involve drug company marketing from Eli Lilly, ... [Modern Practice - 01/14/2010]

Entities: Food and Drug Administration, Warning Letter, Cymbalta, Eli Lilly & Company

First Reported 01/26/2010 - Updated 01/26/2010 - 2 Documents (in Internet & IT)

Amylin Pharma upped to buy at Citi

LONDON (MarketWatch) -- Amylin Pharmaceuticals was upped to buy from hold at Citi on optimism over the potential for approval of its diabetes drug as Novo Nordisk's Victoza was approved. (Corrects spelling of company name in headline.) Market Pulse Stories ... [MarketWatch - 01/26/2010]

Entities: Amylin Pharmaceuticals Inc, MarketWatch Inc, Victoza, Novo Nordisk

First Reported 01/28/2010 - Updated 01/28/2010 - 2 Documents

Amylin Pharmaceuticals Reports 2009 Financial Results - PR Newswire (press release)

2009 Non-GAAP Operating Loss Improves by 57% Over 2008 SAN DIEGO, Jan. 27, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2009. The Company reported ... [Software Developer - 01/28/2010]

Entities: Amylin Pharmaceuticals Inc, Byetta, Exenatide

First Reported 01/13/2010 - Updated 01/13/2010 - 2 Documents

Critical Alerts for Hartford Financial Services, Apple, Yamana Gold, Amylin Pharmaceuticals and MetLife Released by Seven Summits Research

CHICAGO, Jan. 13 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for HIG, AAPL, AUY, AMLN and MET. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/011310B (Note: You may have to copy this ... [SmartBrief - 01/13/2010]

Entities: Hartford Financial Services Group Inc, MetLife Incorporated, Amylin Pharmaceuticals Inc, Yamana Gold Inc, Apple Inc

Quotes

"In this industry they usually use to try and extend their growth, but a lot of times they overreach and it becomes wasteful" said Whitworth, whose firm-- Relational Investors, a $6 billion investment fund--recently has made noise at Genzyme, which has suffered from manufacturing...

Activists Increasingly Like Biotechs But With Mixed Results [Nasdaq - 16 hours ago]

More Content

sort by: Date \| Relevance
Biotech ETFs Immune To Broad Selling [Yahoo! Canada - 10 hours ago]
Alkermes Retains Neutral Rec - Analyst Blog [Benzinga.com - 14 hours ago]
Activists Increasingly Like Biotechs But With M... [Nasdaq - 16 hours ago]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Form 4 AMYLIN PHARMACEUTICALS For:... [Street Insider - 02/05/2010]
Asterand posts documentation on proposed BioSee... [Proactive Investors.co.uk - 02/04/2010]
Asterand posts documentation on proposed BioSee... [Proactiveinvestors United Kingdom RSS feed - 02/04/2010]
Alkermes Unveils Cheaper, Easier Technique for ... [Xconomy - 02/04/2010]
SmarTrend's Trend Spotter Sees Continued Upward... [Individual.com - 02/03/2010]
Novo Nordisk Has High Hopes for Diabetes Blockb... [Seeking Alpha - 02/03/2010]
Novo Nordisk's 4Q profit flat; raises guidance ... [PSL Group - 02/02/2010]
Eli Lilly and the Depression-Diabetes Circle [Minyanville - 02/02/2010]
2-Star Stocks Poised to Plunge: MannKind? [Motley Fool via MSN Money - 02/02/2010]
Weekly Street Sentiment: Mostly Cloudy with a C... [Seeking Alpha - 02/02/2010]
Novo Nordisk Profit Little Changed on Higher Co... [BusinessWeek - 02/02/2010]
PREVIEW-Novo Nordisk Q4 seen down but 2010 rosier [FinanzNachrichten.de - 02/01/2010]
Novo Nordisk Awaits China Approval of Diabetes ... [Seeking Alpha - 01/31/2010]
AstraZeneca, Eli Lilly Foreboding for Sector [MSN Money - 01/30/2010]
Wake Up! You Still Have to Pay Attention [Motley Fool - 01/29/2010]
Form SC 13G AMYLIN PHARMACEUTICALS ... [Street Insider - 01/29/2010]
AstraZeneca, Eli Lilly Foreboding for Sector [Minyanville - 01/29/2010]
Approval of Diamyd's Diabetes Vaccine Set for 2011 [Huliq.com - 01/29/2010]
Eli Lilly returns to profit, poor Effient sales... [Pharma Times - 01/29/2010]

Advanced Search Options

Amylin Pharmaceuticals Inc